Pharmaceuticals & Biotechnology

GlaxoSmithKline Pharmaceuticals Limited

ISIN: INE159A01016 · Data as of Aug 2026
Share: WhatsApp ✕ X
Search another stock:
Active Funds Holding
50
vs Last Month
+1 funds
Total Value
₹2,429.29 Cr
Avg Weight
1.62%
New Entries
10
Exits
9
ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.
Mid Cap Rank #221
₹22.05 K Cr
Avg Mkt Cap · Jan-Jun 2023 (3yr ago)
₹40.59 K Cr
Avg Mkt Cap · Jan-Jun 2026 (latest)
+84.1%
3yr change
SEBI · AMFI Market Cap List
📋 What Changed This Month GlaxoSmithKline Pharmaceuticals Limited is currently held by 50 active mutual funds with total exposure of ₹2,429.29 Cr. This month 10 funds entered and 9 funds exited. quant Healthcare Fund - Growth Option - Direct Plan has the highest allocation at 10.58%. ↓ Scroll down for full fund list and monthly changes.
Trend

How Has Fund Coverage Changed — Last 5 Months?

Month Funds AUM (Cr) AMCs Status
Aug 2026 REFERENCE 50 ₹2,429 48 / 49
Jul 2026 49 ₹2,224 49 / 49 ✅ Complete
Jun 2026 48 ₹1,923 49 / 49 ✅ Complete
May 2026 42 ₹1,633 49 / 49 ✅ Complete
Apr 2026 41 ₹1,677 49 / 49 ✅ Complete

📌 Portfolio changes below are based on Aug 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Aug 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

By Category

Which Fund Categories Hold This Stock?

Category Funds Avg Weight Distribution
Equity 19 2.02%
Mid Cap 10 1.49%
Multi Cap 4 1.08%
Flexi Cap 4 0.94%
ELSS 3 1.49%
Dividend Yield 2 2.44%
Balanced Advantage 2 1.56%
Aggressive Hybrid 2 1.31%
Small Cap 2 1.29%
Multi Asset 2 0.99%
All Holdings

Which 50 Active Funds Hold GlaxoSmithKline Pharmaceuticals Limited?

Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
quant Healthcare Fund - Growth Option - Direct Plan
Quant Mutual Fund
Equity 10.58% ₹45.31 Cr +0.65%
Bandhan Healthcare Fund - Direct Plan - Growth
Bandhan Mutual Fund
Equity 3.68% ₹12.20 Cr +1.19%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Equity 3.31% ₹314.00 Cr +0.65%
Baroda BNP Paribas Dividend Yield Fund
Baroda BNP Paribas Mutual Fund
Dividend Yield 3.28% ₹19.22 Cr +0.51%
quant Dynamic Asset Allocation Fund
Quant Mutual Fund
Equity 2.95% ₹25.15 Cr NEW
quant Mid Cap Fund - Growth Option - Direct Plan
Quant Mutual Fund
Mid Cap 2.93% ₹235.94 Cr +2.6%
BAJAJ FINSERV MULTI CAP FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
Multi Cap 2.84% ₹46.24 Cr +0.27%
Bajaj Finserv Balanced Advantage Fund-Direct Plan-Growth
Bajaj Finserv Mutual Fund
Balanced Advantage 2.75% ₹35.09 Cr +0.33%
Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Tata Mutual Fund
Equity 2.72% ₹42.63 Cr -1.94%
DSP Quant Fund - Direct Plan - Growth
DSP Mutual Fund
Equity 2.39% ₹18.30 Cr +0.34%
The Wealth Company Large & Mid Cap Fund
The Wealth Company Mutual Fund
Mid Cap 2.38% ₹2.65 Cr +0.29%
Helios Mid Cap Fund - Direct Plan - Growth Option
Helios Mutual Fund
Mid Cap 2.3% ₹51.35 Cr +0.29%
BAJAJ FINSERV ELSS TAX SAVER FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
ELSS 2.25% ₹2.07 Cr +0.23%
ICICI Prudential Quant Fund Direct Plan Growth
ICICI Prudential Mutual Fund
Equity 2.17% ₹3.67 Cr +0.16%
Tata Business Cycle Fund-Direct Plan-Growth
Tata Mutual Fund
Equity 1.97% ₹51.24 Cr +0.28%
Explore More
← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.